Fed. Circ. DQs Katten Over Conflicts In Mylan Patent Case
The Federal Circuit has disqualified Katten Muchin Rosenman LLP from representing Mylan in patent cases brought by units of Valeant Pharmaceuticals, ruling that its representation of another Valeant unit presents a...To view the full article, register now.
Already a subscriber? Click here to view full article